1-6 of 6
urate level
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Practice Utilization and Outcomes with Rasburicase Vs Allopurinol for Patients at High Risk of Tumor Lysis Syndrome

Janna Radtchenko, Daniel Lyons, Yvonne Barnes, Scott Milligan, Edward Drea, PharmD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2203.
https://doi.org/10.1182/blood-2019-124319
Published: 2019
Journal Articles

Efficacy and Safety of Two Comparable Single Low Doses of Rasburicase Followed By Allopurinol in Adult Patients with Acute Leukemia

Pankit Vachhani, MD, Craig Freyer, PharmD, BCOP, Jeffrey Baron, PharmD, BCOP, Austin Miller, PhD, Meir Wetzler, MD, James E. Thompson, MD, Elizabeth A. Griffiths, MD, Eunice S. Wang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5052.
https://doi.org/10.1182/blood.V130.Suppl_1.5052.5052
Published: 2017
Journal Articles

Genome-Wide Association Study of Glomerular Filtration Rate in a Cohort of Sickle Cell Disease Patients

Melanie E. Garrett, MS, Karen L. Soldano, B.S., Blair R. Anderson, Eugene P. Orringer, MD, James R. Eckman, MD, Marilyn J. Telen, MD, Allison E. Ashley-Koch, PhD
Journal: Blood
Blood (2014) 124 (21): 1381.
https://doi.org/10.1182/blood.V124.21.1381.1381
Published: 2014
Journal Articles

High Mortality In Extreme Hyperleukocytosis In Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group.

Lillian Sung, MD, PhD, Todd A. Alonzo, PhD, Robert B. Gerbing, MS, Richard Aplenc, MD, MSCE, Soheil Meshinchi, MD, PhD, Laura Burden, CCRP, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Samir Kahwash, MD, Amy Heerema-McKenney, MD, Laura Winter, PharmD, Kathleen Glick, BA, CCRP, Patti Byron, MSN, RN, Tanya Wallas, MS, Franklin O. Smith, MD, Alan S. Gamis, MD, MPH
Journal: Blood
Blood (2010) 116 (21): 1072.
https://doi.org/10.1182/blood.V116.21.1072.1072
Published: 2010
Journal Articles

Impact of Organic Anion Transporter 3 (OAT3) on Bendamustine Uptake of Lymphoma Cells.

Yohannes Hagos, PhD, Gerald G. Wulf, Md, Vladimir Shnitsar, Ms, Philip Hundertmark, Md, Shvangi Gupta, Ms, Gerhard Burckhardt, Md
Journal: Blood
Blood (2007) 110 (11): 4184.
https://doi.org/10.1182/blood.V110.11.4184.4184
Published: 2007
Journal Articles

Activity of the Histone Deacetylase (HDAC) Inhibitor PXD101 in Preclinical Studies and in a Phase I Study in Patients with Advanced Haematological Tumors.

Peter Gimsing, MD, Frank Wu, PhD, Xiaozhong Qian, PhD, Michael Jeffers, PhD, Lene Knudsen, MD, Maxwell Sehested, MD, PhD, Henri S. Lichenstein, PhD
Journal: Blood
Blood (2005) 106 (11): 3337.
https://doi.org/10.1182/blood.V106.11.3337.3337
Published: 2005